TGF-beta as a T cell regulator in colitis and colon cancer.
about
Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in Smad3(-/-) mice with dysregulated TGFβTGFbeta in CancerDifferential cytokine gene expression profiles in the three pathological forms of sheep paratuberculosis.Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expressionChronic cyclooxygenase-2 inhibition promotes myofibroblast-associated intestinal fibrosis.Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?A cytokine-mediated link between innate immunity, inflammation, and cancer.The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studiesPolyunsaturated fatty acids modify expression of TGF-β in a co-culture model ultilising human colorectal cells and human peripheral blood mononuclear cells exposed to Lactobacillus gasseri, Escherichia coli and Staphylococcus aureus.Thrombospondin-1: multiple paths to inflammation.Moxibustion and Acupuncture Ameliorate Crohn's Disease by Regulating the Balance between Th17 and Treg Cells in the Intestinal Mucosa.Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.Astragalus polysaccharide attenuates rat experimental colitis by inducing regulatory T cells in intestinal Peyer's patches.Mouse models for the study of colon carcinogenesis.Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease.Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer.TGF-β in progression of liver diseaseColorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice.p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF-beta1 secretion and enhances the anti-proliferative effect of 5-fluorouracilTGFbeta1 expression in colonic mucosa: modulation by dietary lipids.High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice.The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas.Colon cancer and the immune system: the role of tumor invading T cells.Immunosuppressive mechanisms of regulatory dendritic cells in cancer.Reduced responsiveness of HLA-B27 transgenic rat cells to TGF-beta and IL-10-mediated regulation of IFN-gamma production.Calotropin regulates the apoptosis of non‑small cell cancer by regulating the cytotoxic T‑lymphocyte associated antigen 4‑mediated TGF‑β/ERK signaling pathway.Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1.Ki-67, TGF-β1, and elastin content are significantly altered in lip carcinogenesis.
P2860
Q21559539-7F54F6AF-2214-4BA5-94A6-67831014ADFFQ28288866-B6A7EABA-10BF-405B-BD79-1E27EF641B52Q33294117-4BBA8AD6-D036-49DD-96E8-8D2F00E60972Q33639952-D1DA4D55-26BE-42C5-A8EB-FB7040D79F85Q33708065-E314365E-70C3-4BFD-B215-66D9009FA84FQ34137246-EA67EABF-8E9D-4D8D-B5E5-F56DCB03DE14Q34625152-CAEB2BEC-1EA8-4339-99EA-9A658324D52CQ34772160-5F17628B-12F9-4185-9AAE-BD505E1DCEF2Q34802933-ABEB1A23-8825-40B4-B25D-3F2255AFC081Q35098885-CCF31BB5-40BB-4986-9DDF-E548A9034C85Q35963975-571EC013-77ED-4F33-8F62-FD1EAB3B424BQ36100192-EBEDC9C8-6C9A-4907-9D2B-641AF9800BFEQ36629839-6D8E24AF-AC9E-434F-A0E0-64646455D6E0Q36682599-21353F01-1E67-4A8C-BB68-E859EF570C47Q37090445-468C0489-5500-4014-896E-DCE8948BB812Q37692380-60D4C672-D77B-4809-83D0-1565F079357AQ37789682-4CE97EF9-F5ED-452D-A7FD-AD8F56F1A222Q37946756-1656C590-8038-427D-A121-33E980D1BF53Q38105801-62E9702D-69F5-46BE-BDA8-16D7E45FCA3CQ38598113-D2EACDF4-FF2E-4073-AB2E-533BE92B5D63Q39378252-97D26589-F047-4E74-BA67-E110DDCEF370Q39860298-0A3F7489-BB68-46E5-AC99-37BE3CEAA4C8Q40622411-552F7491-2C3A-480E-8C19-A1D23F1DC6FFQ40877975-42A6BD32-770C-4E47-AA0B-426A652BE5A8Q41500559-0942D853-5863-4E2A-9576-7F395210565EQ42571176-F68D898A-153A-4380-B734-CBDC0236BF98Q42725940-FB574168-D95E-4C20-9C73-168E0BD2E018Q43084328-0F28E043-3866-42FD-BFD6-3F14DBD6E7E3Q46702165-B440F2B5-47D7-4932-A328-6CFACE73725BQ52605251-5ED55266-B40D-4B83-83C3-13009922A93EQ52845203-BC653DED-23FC-497C-8E4A-EA8AF4C2C30FQ53238186-F75C75FC-0901-4947-BB0C-0F7C987C2C25
P2860
TGF-beta as a T cell regulator in colitis and colon cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
TGF-beta as a T cell regulator in colitis and colon cancer.
@ast
TGF-beta as a T cell regulator in colitis and colon cancer.
@en
type
label
TGF-beta as a T cell regulator in colitis and colon cancer.
@ast
TGF-beta as a T cell regulator in colitis and colon cancer.
@en
prefLabel
TGF-beta as a T cell regulator in colitis and colon cancer.
@ast
TGF-beta as a T cell regulator in colitis and colon cancer.
@en
P1476
TGF-beta as a T cell regulator in colitis and colon cancer
@en
P2093
Markus F Neurath
Massimo C Fantini
P304
P356
10.1016/J.CYTOGFR.2005.09.004
P577
2005-11-18T00:00:00Z